Literature DB >> 27191123

The FDA and ECT.

William M McDonald1, Richard D Weiner, Laura J Fochtmann, W Vaughn McCall.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27191123      PMCID： PMC5137581          DOI： 10.1097/YCT.0000000000000326

Source DB:  PubMed          Journal:  J ECT        ISSN： 1095-0680            Impact factor:   3.635


× No keyword cloud information.
  14 in total

Review 1.  Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report.

Authors:  Melissa Frederikse; Georgios Petrides; Charles Kellner
Journal:  J ECT       Date:  2006-03       Impact factor: 3.635

Review 2.  ECT for treatment-resistant schizophrenia: a response from the far East to the UK. NICE report.

Authors:  Worrawat Chanpattana; Chittaranjan Andrade
Journal:  J ECT       Date:  2006-03       Impact factor: 3.635

3.  Electroconvulsive therapy.

Authors:  Stuart Carney; John Geddes
Journal:  BMJ       Date:  2003-06-21

4.  Improving Practice in Electroconvulsive Therapy: A Nationwide Survey in Belgium.

Authors:  Pascal Sienaert; Tamara Falconieri; Jasmien Obbels; Hans van den Ameele; Filip Bouckaert
Journal:  J ECT       Date:  2016-03       Impact factor: 3.635

5.  Challenges to British practice of electroconvulsive therapy.

Authors:  Max Fink
Journal:  J ECT       Date:  2006-03       Impact factor: 3.635

6.  Mental illness surveillance among adults in the United States.

Authors:  William C Reeves; Tara W Strine; Laura A Pratt; William Thompson; Indu Ahluwalia; Satvinder S Dhingra; Lela R McKnight-Eily; Leslie Harrison; Denise V D'Angelo; Letitia Williams; Brian Morrow; Deborah Gould; Marc A Safran
Journal:  MMWR Suppl       Date:  2011-09-02

7.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

Authors:  Charles H Kellner; Rebecca G Knapp; Georgios Petrides; Teresa A Rummans; Mustafa M Husain; Keith Rasmussen; Martina Mueller; Hilary J Bernstein; Kevin O'Connor; Glenn Smith; Melanie Biggs; Samuel H Bailine; Chitra Malur; Eunsil Yim; Shawn McClintock; Shirlene Sampson; Max Fink
Journal:  Arch Gen Psychiatry       Date:  2006-12

Review 8.  Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.

Authors:  Elizabeth Reisinger Walker; Robin E McGee; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

9.  Electroconvulsive Therapy Practice in Spain: A National Survey.

Authors:  Ignacio Vera; Javier Sanz-Fuentenebro; Mikel Urretavizcaya; Ernesto Verdura; Virginia Soria; Erika Martínez-Amorós; Miquel Bernardo
Journal:  J ECT       Date:  2016-03       Impact factor: 3.635

10.  Excess mortality due to depression and anxiety in the United States: results from a nationally representative survey.

Authors:  Laura A Pratt; Benjamin G Druss; Ronald W Manderscheid; Elizabeth Reisinger Walker
Journal:  Gen Hosp Psychiatry       Date:  2015-12-18       Impact factor: 3.238
View more
  3 in total

Review 1.  A narrative review on invasive brain stimulation for treatment-resistant depression.

Authors:  Manoj P Dandekar; Alexandre P Diaz; Ziaur Rahman; Ritele H Silva; Ziad Nahas; Scott Aaronson; Sudhakar Selvaraj; Albert J Fenoy; Marsal Sanches; Jair C Soares; Patricio Riva-Posse; Joao Quevedo
Journal:  Braz J Psychiatry       Date:  2022 May-Jun

2.  Effectiveness of electroconvulsive therapy in patients with "less treatment-resistant" depression by the Maudsley Staging Model.

Authors:  Yarong Ma; Robert Rosenheck; Biyu Ye; Ni Fan; Hongbo He
Journal:  Brain Behav       Date:  2020-05-13       Impact factor: 2.708

3.  Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review.

Authors:  Saskia Hendriks; Christine Grady; Khara M Ramos; Winston Chiong; Joseph J Fins; Paul Ford; Sara Goering; Henry T Greely; Katrina Hutchison; Michael L Kelly; Scott Y H Kim; Eran Klein; Sarah H Lisanby; Helen Mayberg; Hannah Maslen; Franklin G Miller; Karen Rommelfanger; Sameer A Sheth; Anna Wexler
Journal:  JAMA Neurol       Date:  2019-10-17       Impact factor: 29.907
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.